Marc Balkin - Jan 10, 2024 Form 4 Insider Report for Newcourt Acquisition Corp (NCAC)

Role
Director, 10%+ Owner
Signature
/s/ Marc Balkin
Stock symbol
NCAC
Transactions as of
Jan 10, 2024
Transactions value $
$0
Form type
4
Date filed
1/16/2024, 05:20 PM
Previous filing
Oct 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NCAC Class A Ordinary Shares, par value $0.0001 Other +7.46M 7.46M Jan 10, 2024 See Footnote F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NCAC Private Warrants Other +460K 460K Jan 10, 2024 Ordinary Shares 460K $11.50 See Footnote F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 10, 2024, Mr. Balkin was appointed as managing member of Newcourt SPAC Sponsor LLC (the "Sponsor").
F2 Represents (i) 6,535,000 Class B ordinary shares of the issuer that were acquired by the Sponsor pursuant to a subscription agreement by and between the Sponsor and the issuer prior to the issuer's initial public offering, and (ii) 920,000 Class A ordinary shares of the issuer purchased by the Sponsor in a private placement that closed simultaneously with the issuer's initial public offering. On October 20, 2023, the Sponsor elected to convert its Class B ordinary shares into Class A ordinary shares on a one-for-one basis. As a result, 6,535,000 of the Company's Class B ordinary shares were cancelled and 6,535,000 Class A Shares were issued to the Sponsor.
F3 Mr. Balkin is sole managing member of the Sponsor and may be deemed to hold beneficial ownership of the securities held directly by the Sponsor.
F4 These private placement warrants were acquired by the Sponsor in a private placement that closed simultaneously with the issuer's initial public offering. The warrants may be exercised commencing 30 days after the consummation of the Business Combination.

Remarks:

Mr. Balkin disclaims any beneficial ownership of the securities reported herein other than to the extent of any pecuniary interest he may have therein, directly or indirectly. The inclusion of the securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose or that any of the transactions reported herein are subject to Section 16.